Aptima SARS-CoV-2 Assay
HSA Provisional Authorisation
*Professional Use Only
The Aptima™ SARS-CoV-2 assay is a nucleic acid amplification in-vitro diagnostic test intended for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal (NP), nasal, mid-turbinate, and oropharyngeal (OP) swab specimens, nasopharyngeal wash/ aspirate or nasal aspirates obtained from individuals meeting COVID-19 clinical and/or epidemiological criteria.
Authorized for use in both symptomatic and asymptomatic people.
Power of sensitivity: Most analytically sensitive, fully-automated, high-throughput
Flexible: A single patient specimen can be tested for SARS-CoV-2 as well as other
common respiratory viruses with symptoms that overlap with COVID-19 boosting efficiency and increasing clinical insight.
For use with nasopharyngeal (NP), nasal, mid-turbinate, and oropharyngeal (OP) swab specimens, nasopharyngeal wash/aspirate, or nasal wash.
✓ Viral transport medium (VTM/UTM)
✓ Liquid Amies
✓ Specimen transport medium (STM)
✓ Aptima® Multitest Swab Specimen Collection Kit